Who is eligible for clinical trial NCT06847685?

Participants must meet protocol criteria for Endometriosis. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06847685 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-03-06

Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study) (NCT06847685)

🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Johns Hopkins University

🩺 Plain-English Summary (8th-Grade Level)

The researchers are evaluating mechanisms of uterine fluid absorption during early pregnancy

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (9 items) and avoid the listed exclusions (7 items).

Location: University of Georgia — Athens, Georgia

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Subject must be a healthy woman between the ages of 18 and 45 years.
Women with diagnosed endometriosis or infertility (cases).
Women without a diagnosis of endometriosis or infertility (controls).
Subject must have regular menstrual cycles.
Subject must have a body mass index (BMI) between 18 and 40.
Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
Subject must be able to understand and provide consent to procedures and use/disclosure of protected health information.
No history of Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, hepatitis B, and HIV.
For IVF study subjects, a minimum endometrial thickness of 7mm at the time of sample collection.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Pregnant women.
Study subjects with endometrial cancer.
Study subjects with a history of endometrial ablation.
Study subjects with undiagnosed uterine bleeding.
Women with reproductive diseases that affect the endometrium (such as fibroids or uterine polyps that distort endometrial cavity).
Study subjects with an intrauterine device (IUD).

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (3 Sites)

University of Georgia — Athens, Georgia
Johns Hopkins Hospital — Baltimore, Maryland
Rutgers University — Piscataway, New Jersey

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗